Literature DB >> 20647575

A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Barry L Carter1, William Clarke, Gail Ardery, Cynthia A Weber, Paul A James, Mark Vander Weg, Elizabeth A Chrischilles, Thomas Vaughn, Brent M Egan.   

Abstract

UNLABELLED: Numerous studies have demonstrated the value of team-based care to improve blood pressure (BP) control, but there is limited information on whether these models would be adopted in diverse populations. The purpose of this study was to evaluate whether a collaborative model between physicians and pharmacists can improve BP control in multiple primary care medical offices with diverse geographic and patient characteristics and whether long-term BP control can be sustained. This study is a randomized prospective trial in 27 primary care offices first stratified by the percentage of underrepresented minorities and the level of clinical pharmacy services within the office. Each office is then randomized to either a 9- or 24-month intervention or a control group. Patients will be enrolled in this study until 2012. The results of this study should provide information on whether this model can be implemented in large numbers of diverse offices, if it is effective in diverse populations, and whether BP control can be sustained long term. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00935077.

Entities:  

Mesh:

Year:  2010        PMID: 20647575      PMCID: PMC2931811          DOI: 10.1161/CIRCOUTCOMES.109.908038

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  26 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 2.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

3.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

4.  Development of explicit criteria to measure adherence to hypertension guidelines.

Authors:  J L Milchak; B L Carter; G Ardery; H R Black; G L Bakris; D W Jones; C D Kreiter
Journal:  J Hum Hypertens       Date:  2006-06       Impact factor: 3.012

5.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

6.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

7.  Statistical considerations in the design and analysis of community intervention trials.

Authors:  A Donner; N Klar
Journal:  J Clin Epidemiol       Date:  1996-04       Impact factor: 6.437

8.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

9.  Hypertensive patients' race, health beliefs, process of care, and medication adherence.

Authors:  Nancy R Kressin; Fei Wang; Judith Long; Barbara G Bokhour; Michelle B Orner; James Rothendler; Christine Clark; Surekha Reddy; Waldemar Kozak; Laura P Kroupa; Dan R Berlowitz
Journal:  J Gen Intern Med       Date:  2007-03-16       Impact factor: 5.128

10.  A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; George R Bergus; Jeffrey D Dawson; Karen B Farris; William R Doucette; Elizabeth A Chrischilles; Arthur J Hartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

View more
  26 in total

1.  Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Authors:  Barry L Carter; Barcey Levy; Brian Gryzlak; Yinghui Xu; Elizabeth Chrischilles; Jeffrey Dawson; Mark Vander Weg; Alan Christensen; Paul James; Linnea Polgreen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

2.  Physician-pharmacist collaborative management of asthma in primary care.

Authors:  Tyler H Gums; Barry L Carter; Gary Milavetz; Lucinda Buys; Kurt Rosenkrans; Liz Uribe; Christopher Coffey; Eric J MacLaughlin; Rodney B Young; Adrienne Z Ables; Nima Patel-Shori; Angela Wisniewski
Journal:  Pharmacotherapy       Date:  2014-08-20       Impact factor: 4.705

3.  Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

Authors:  Maxwell D Anderegg; Tyler H Gums; Liz Uribe; Christopher S Coffey; Paul A James; Barry L Carter
Journal:  Hypertension       Date:  2016-09-06       Impact factor: 10.190

4.  A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Authors:  Linnea A Polgreen; Barry L Carter; Philip M Polgreen; Peter M Snyder; Daniel K Sewell; Emine O Bayman; Shelby L Francis; Jacob E Simmering; Christopher Parker; Rachel Finkelstein
Journal:  Contemp Clin Trials       Date:  2020-10-07       Impact factor: 2.226

Review 5.  Translational science matters: forging partnerships between biomedical and behavioral science to advance the public's health.

Authors:  George A Mensah; Susan M Czajkowski
Journal:  Transl Behav Med       Date:  2018-09-08       Impact factor: 3.046

6.  Sustained blood pressure control following discontinuation of a pharmacist intervention.

Authors:  Danielle M Wentzlaff; Barry L Carter; Gail Ardery; Carrie L Franciscus; William R Doucette; Elizabeth A Chrischilles; Kurt A Rosenkrans; Lucinda M Buys
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

Review 7.  Cluster randomized trials for pharmacy practice research.

Authors:  Tyler Gums; Barry Carter; Eric Foster
Journal:  Int J Clin Pharm       Date:  2015-12-29

8.  Pharmacist intervention for blood pressure control: medication intensification and adherence.

Authors:  Tyler H Gums; Liz Uribe; Mark W Vander Weg; Paul James; Christopher Coffey; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2015-05-15

9.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

Review 10.  Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care.

Authors:  Barry L Carter
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.